ANVISA
-
Hospitals
Bioventus Receives ANVISA Approval to Market DUROLANE® in Brazil and Selects Pfizer as Exclusive Distribution Partner
October 02, 2018 HOOFDDORP, Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de Vigilância…
Read More » -
Hospitals
VEXIM: ANVISA Approves SpineJack® Implants in Brazil
May 29, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally…
Read More » -
Hospitals
ANVISA regulatory approval granted in Brazil to market the JAZZ BandTM platform
IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it…
Read More »